This table shows the probability of having each of the four pathologic stages of prostate cancer based on Gleason score, clinical stage and a PSA level between 10.1 and 20.0 ng/ml.
Examples
|
PSA = 10.1
20.0 ng/ml
|
Probability
of Pathologic Stage (%)
|
|
Clinical
Stage
|
||||||||
|
Gleason
score
|
Pathologic stage |
T1a |
T1b
|
T1c |
T2a |
T2b |
T2c
|
T3a |
|
2-4
|
Organ-confined
disease Established capsular penetration Seminal vesicle involvement Lymph node involvement |
|
|
|
|
|
|
|
|
5
|
Organ-confined
disease Established capsular penetration Seminal vesicle involvement Lymph node involvement |
|
|
|
|
|
|
|
|
6
|
Organ-confined
disease Established capsular penetration Seminal vesicle involvement Lymph node involvement |
|
|
|
|
|
|
|
|
7
|
Organ-confined
disease Established capsular penetration Seminal vesicle involvement Lymph node involvement |
|
|
|
|
|
|
|
|
8-10
|
Organ-confined
disease Established capsular penetration Seminal vesicle involvement Lymph node involvement |
|
|
|
|
|
|
|
Reference: Partin AW, Kattan MW, Subong EN, Walsh PC, et al. Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer: A multi-institutional update. JAMA 1997;277:1445-1451. Copyrighted 1997, American Medical Association. Reprinted with permission.
About This Web Site
|
Give Us Your Feedback
|
Privacy Statement
|
Disclaimer
|
Site Statistics
|
Informatics Web Resources
©
UPMC, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
412-647-2811
|
PCI-INFO@upmc.edu
|
Designed and maintained by the Department of Biomedical Informatics
Send questions and comments to UPCIwebupdates@upmc.edu
